Abstract
BackgroundThe effectiveness of anti-tumor necrosis factor -alpha therapy (anti-TNF-α) is well known, but the discontinuation of this therapy is insufficiently studied.ObjectivesTo analyze consequences and safety of anti-TNF-α therapy after discontinuation...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
